Signal transduction in the hypothalamic corticotropin-releasing factor system and its clinical implications

Stress

Volumn 14, Issue 4, 2011, Pages 357-367

  Kageyama, Kazunori ^a   Tamasawa, Naoki ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Corticotropin releasing factor; hypothalamus; stress; cyclic AMP; IL 6

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; ESTROGEN; FORSKOLIN; FURIN; GLUCOCORTICOID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 6; MESSENGER RNA; P21 ACTIVATED KINASE 3; PROOPIOMELANOCORTIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INTERLEUKIN-6; MICE; NELSON SYNDROME; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTOR AP-1;

EID: 79958857364     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2010.536279     Document Type: Review

References (62)

1. Agarwal A, Halvorson LM, Legradi G. 2005. Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res Mol Brain Res 138:45-57. (Pubitemid 41032929)
2. Al-Gahtany M, Horvath E, Kovacs K. 2003. Pituitary hyperplasia. Hormones (Athens) 2:149-158.
3. Auernhammer CJ, Bousquet C, Melmed S. 1999. Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 96: 6964-6969. (Pubitemid 29274993)
4. Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R. 2004. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 279:1422-1428. (Pubitemid 38082670)
5. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. 1989. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237-239. (Pubitemid 19020112)
6. Cheng YH, Nicholson RC, King B, Chan EC, Fitter JT, Smith R. 2000. Glucocorticoid stimulation of corticotropin-releasing hormone gene expression requires a cyclic adenosine 3,5-monophosphate regulatory element in human primary placental cytotrophoblast cells. J Clin Endocrinol Metab 85: 1937-1945. (Pubitemid 32269302)
7. Childs GV, Rougeau D, Unabia G. 1995. Corticotropin-releasing hormone and epidermal growth factor: Mitogens for anterior pituitary corticotropes. Endocrinology 136:1595-1602.
8. Foulkes NS, Borrelli E, Sassone-Corsi P. 1991. CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 64:739-749. (Pubitemid 121001161)
9. Fukuda Y, Kageyama K, Nigawara T, Kasagi Y, Suda T. 2004. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: A study using CRH-deficient mice. Neurosci Lett 367:201-204. (Pubitemid 39141227)
10. Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG, Murphy D. 2003. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem 278:19280-19285. (Pubitemid 36799320)
11. Gillies GE, Linton EA, Lowry PJ. 1982. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355-357. (Pubitemid 12012863)
12. Grinevich V, Fournier A, Pelletier G. 1997. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res 773: 190-196. (Pubitemid 27521123)
13. Guardiola-Diaz HM, Kolinske JS, Gates LH, Seasholtz AF. 1996. Negative glucocorticoid regulation of cyclic adenosine 3,5-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol Endocrinol 10: 317-329.
14. Jacobson L, Sharp FR, Dallman MF. 1990. Induction of fos-like immunoreactivity in hypothalamic corticotropin-releasing factor neurons after adrenalectomy in the rat. Endocrinology 126: 1709-1719. (Pubitemid 20095783)
15. Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T. 2007. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopres-sin, and interleukin-6 gene transcription in hypothalamic 4B cells. J Encocrinol 195:199-211. (Pubitemid 350143101)
16. Kageyama K, Hanada K, Takayasu S, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T. 2008. Involvement of regulatory elements on corticotropin-releasing factor gene promoter in hypothalamic 4B cells. J Endocrinol Invest 31: 1079-1085.
17. Kageyama K, Hanada K, Iwasaki Y, Suda T. 2009a. Regulation and role of suppressor of cytokine signaling-3 in hypothalamic 4B cells. J Endocrinol 201:369-376.
18. Kageyama K, Sakihara S, Suda T. 2009b. Regulation and role of p21-activated kinase 3 by corticotropin-releasing factor in mouse pituitary. Regul Pept 152:88-94.
19. Kageyama K, Akimoto K, Suda T. 2010. Corticotropin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells. J Neuroendocrinol 22: 971-978.
20. Karagianni N, Tsawdaroglou N. 1994. The c-fos serum response element (SRE) confers negative response to glucocorticoids. Oncogene 9:2327-2334. (Pubitemid 24228684)
21. Karalis K, Muglia LJ, Bae D, Hilderbrand JA. 1997. CRH and the immune system. J Neuroimmunol 72:131-136. (Pubitemid 27062768)
22. King BR, Smith R, Nicholson RC. 2002. Novel glucocorticoid and cAMP interactions on the CRH gene promoter. Mol Cell Endocrinol 194:19-28. (Pubitemid 35291916)
23. Knaus UG, Morris S, Dong HJ, Chernoff J, Bokoch GM. 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269:221-223.
24. Krebs DL, Hilton DJ. 2000. SOCS: Physiological suppressors of cytokine signaling. J Cell Sci 113:2813-2819.
25. Lalli E, Sassone-Corsi P. 1994. Signal transduction and gene regulation: The nuclear response to cAMP. J Biol Chem 269: 17359-17362. (Pubitemid 24218002)
26. Legradi G, Holzer D, Kapcala LP, Lechan RM. 1997. Glucocorti-coids inhibit stress-induced phosphorylation of CREB in corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology 66:86-97. (Pubitemid 27309834)
27. Ma XM, Aguilera G. 1999. Differential regulation of corticotropin- releasing hormone and vasopressin transcription by glucocorti-coids. Endocrinology 140:5642-5650. (Pubitemid 30645352)
28. Malkoski SP, Dorin RI. 1999. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol 13:1629-1644. (Pubitemid 30645269)
29. Manser E, Huang HY, Loo TH, Chen XQ, Dong JM, Leung T, Lim L. 1997. Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 17:1129-1143. (Pubitemid 27097342)
30. McPhie DL, Coopersmith R, Hines-Peralta A, Chen Y, Ivins KJ, Manly SP, Kozlowski MR, Neve KA, Neve RL. 2003. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J Neurosci 23:6914-6927. (Pubitemid 36951220)
31. Melzig MF, Papsdorf G, Loose R, Winkler A, Beyermann M, Krause E, Zipper J. 1998. Effects of long-term treatment with corticotropin-releasing factor on corticotropic tumor cells in vitro. Regul Pept 74:35-40. (Pubitemid 28234174)
32. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574. (Pubitemid 19269770)
33. Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P. 1993. Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor. Cell 75:875-886. (Pubitemid 24014545)
34. Mouri T, Itoi K, Takahashi K, Suda T, Murakami O, Yoshinaga K, Andoh N, Ohtani H, Masuda T, Sasano N. 1993. Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 57:34-39. (Pubitemid 23091885)
35. Muglia LJ, Jenkins NA, Gilbert DJ, Copeland NG, Majzoub JA. 1994. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J Clin Invest 93:2066-2072. (Pubitemid 24143087)
36. Muglia L, Jacobson L, Dikkes P, Majzoub JA. 1995. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432.
37. Muglia LJ, Jacobson L, Weninger SC, Luedke CE, Bae DS, Jeong KH, Majzoub JA. 1997. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J Clin Invest 99:2923-2929. (Pubitemid 27278669)
38. Muglia LJ, Jacobson L, Luedke C, Vogt SK, Schaefer ML, Dikkes P, Fukuda S, Sakai Y, Suda T, Majzoub JA. 2000. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest 105:1269-1277. (Pubitemid 30266080)
39. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. 1991. Interleukins-1 and-6 stimulate the release of corticotropin-releasing hormone-41 from rat hypo-thalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128:37-44.
40. Nomura M, Ueta Y, Serino R, Kabashima N, Shibuya I, Yamashita H. 1996. PACAP type I receptor gene expression in the paraventricular and supraoptic nuclei of rats. Neuroreport 8: 67-70. (Pubitemid 126785533)
41. Ochedalski T, Subburaju S, Wynn PC, Aguilera G. 2007. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J Neuroendocrinol 19:189-197. (Pubitemid 46210946)
42. Ogura E, Kageyama K, Hanada K, Kasckow J, Suda T. 2008. Effects of estradiol on regulation of corticotropin-releasing factor gene and interleukin-6 production via estrogen receptor type beta in hypothalamic 4B cells. Peptides 29:456-464.
43. Ram PA, Waxman DJ. 1999. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274:35553-35561. (Pubitemid 129512851)
44. Schimpl A, Wecker E. 1972. Replacement of T-cell function by a T-cell product. Nat New Biol 237:15-17.
45. Schmitz J, Weissenbach M, Haan S, Heinrich PC, Schaper F. 2000. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem 275:12848-12856. (Pubitemid 30241440)
46. Seasholtz AF, Thompson RC, Douglass JO. 1988. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol Endocrinol 2: 1311-1319. (Pubitemid 19005944)
47. Shioda S, Shuto Y, Somogyvari-Vigh A, Legradi G, Onda H, Coy DH, Nakajo S, Arimura A. 1997. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci Res 28: 345-354. (Pubitemid 27348184)
48. Spengler D, Rupprecht R, Van LP, Holsboer F. 1992. Identification and characterization of a 3,5-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol 6:1931-1941.
49. Suda T, Tozawa F, Yamaguchi H, Shibasaki T, Demura H, Shizume K. 1982. Multiple forms of immunoreactive ß-endorphin are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas. J Clin Endocrinol Metab 54:167-171. (Pubitemid 13242152)
50. Suda T, Yajima F, Tomori N, Demura H, Shizume K. 1985. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. Life Sci 37:1499-1505. (Pubitemid 15239536)
51. Suda T, Kondo M, Totani R, Hashimoto N, Suzuki M, Imaki T, Oba Y, Tomori N, Tozawa F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K. 1986. Ectopic adreno-corticotropin syndrome caused by lung cancer that responded to corticotropin-releasing hormone. J Clin Endocrinol Metab 63: 1047-1051. (Pubitemid 17173035)
52. Takaki A, Huang QH, Somogyvari-Vigh A, Arimura A. 1994. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodula-tion 1:335-342.
53. Turnbull AV, Rivier CL. 1999. Regulation of the hypothalamic-pituitary- adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 79:1-71. (Pubitemid 29056948)
54. Vale W, Spiess J, Rivier C, Rivier J. 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-1397. (Pubitemid 12243637)
55. Vallieres L, Rivest S. 1999. Interleukin-6 is a needed proinflamma-tory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 140:3890-3903. (Pubitemid 30647082)
56. van der Laan S, Lachize SB, Vreugdenhil E, de Kloet ER, Meijer OC. 2008. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene. Endocrinology 149:725-732. (Pubitemid 351159322)
57. van Wijk PA, van Neck JW, Rijnberk A, Croughs RJ, Mol JA. 1995. Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids. Mol Cell Endocrinol 111:13-19.
58. Venihaki M, Dikkes P, Carrigan A, Karalis KP. 2001. Corticotropin- releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 108:1159-1166. (Pubitemid 32995374)
59. Yamamori E, Asai M, Yoshida M, Takano K, Itoi K, Oiso Y, Iwasaki Y. 2004. Calcium/calmodulin kinase IV pathway is involved in the transcriptional regulation of the corticotropin-releasing hormone gene promoter in neuronal cells. J Mol Endocrinol 33:639-649. (Pubitemid 40057559)
60. Yao M, Denver RJ. 2007. Regulation of vertebrate corticotropin-releasing factor genes. Gen Comp Endocrinol 153:200-216. (Pubitemid 47102329)
61. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, Bokoch GM. 1995. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 270:23934-23936.
62. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. 1993. Exposure to physical and psychological stressors elevates plasma interleukin 6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133:2523-2530. (Pubitemid 24000698)